First Trust Advisors’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-14,865
Closed -$722K 2467
2022
Q4
$722K Sell
14,865
-98
-0.7% -$6.15K ﹤0.01% 2070
2022
Q3
$1.06M Buy
14,963
+10,665
+248% +$913K ﹤0.01% 1979
2022
Q2
$305K Buy
+4,298
New +$277K ﹤0.01% 2300
2022
Q1
Sell
-35,458
Closed -$3.24M 2588
2021
Q4
$3.24M Sell
35,458
-16,395
-32% -$1.76M ﹤0.01% 1586
2021
Q3
$6.67M Sell
51,853
-1,693
-3% -$237K 0.01% 1147
2021
Q2
$8.17M Sell
53,546
-6,332
-11% -$834K 0.01% 1072
2021
Q1
$6.31M Buy
59,878
+10,055
+20% +$1.01M 0.01% 1107
2020
Q4
$3.95M Buy
49,823
+12,478
+33% +$913K 0.01% 1205
2020
Q3
$2.11M Sell
37,345
-18,256
-33% -$983K ﹤0.01% 1343
2020
Q2
$3.42M Sell
55,601
-638
-1% -$26.1K 0.01% 1129
2020
Q1
$1.81M Buy
+56,239
New +$1.9M ﹤0.01% 1315
2019
Q3
Sell
-35,263
Closed -$1.04M 2471
2019
Q2
$1.04M Sell
35,263
-31,355
-47% -$905K ﹤0.01% 1841
2019
Q1
$2.28M Sell
66,618
-33,922
-34% -$1.2M ﹤0.01% 1484
2018
Q4
$3.21M Buy
+100,540
New +$3.92M 0.01% 1215

Other funds holding STAA

First Trust Advisors's STAA Position: Q1 2023 in Review

First Trust Advisors sold out of STAAR Surgical (STAA) in Q1 2023, closing a stake of 14,865 shares — an estimated $722K sold.

First Trust Advisors first reported a position in STAA in Q4 2018 and held it in 14 quarters. The position peaked at $8.17M in Q2 2021. 251 funds tracked by Wall St. Rank hold STAA as of Q1 2023.

  • First Trust Advisors reported no remaining STAAR Surgical position as of Q1 2023 after selling out during the quarter.
  • First Trust Advisors sold 14,865 STAAR Surgical shares in Q1 2023, an estimated $722K.
  • First Trust Advisors first reported a position in STAAR Surgical in Q4 2018 and held it in 14 quarters.
  • First Trust Advisors's STAAR Surgical position peaked at $8.17M in Q2 2021.
  • 251 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2023.

Based on First Trust Advisors's 13F filing for Q1 2023, filed 15 May 2023.